Keybank National Association OH Decreases Position in Solventum Co. (NYSE:SOLV)

Keybank National Association OH decreased its holdings in Solventum Co. (NYSE:SOLV) by 5.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 42,386 shares of the company’s stock after selling 2,258 shares during the period. Keybank National Association OH’s holdings in Solventum were worth $2,800,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of SOLV. Janney Montgomery Scott LLC raised its holdings in Solventum by 9.8% in the 3rd quarter. Janney Montgomery Scott LLC now owns 42,931 shares of the company’s stock valued at $2,993,000 after acquiring an additional 3,848 shares during the last quarter. Van ECK Associates Corp increased its holdings in shares of Solventum by 53.9% during the 3rd quarter. Van ECK Associates Corp now owns 36,694 shares of the company’s stock worth $2,660,000 after buying an additional 12,847 shares during the last quarter. Robeco Institutional Asset Management B.V. increased its holdings in shares of Solventum by 29.0% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 27,826 shares of the company’s stock worth $1,940,000 after buying an additional 6,260 shares during the last quarter. Asset Management One Co. Ltd. increased its holdings in shares of Solventum by 0.9% during the 3rd quarter. Asset Management One Co. Ltd. now owns 53,597 shares of the company’s stock worth $3,737,000 after buying an additional 464 shares during the last quarter. Finally, Radnor Capital Management LLC increased its holdings in shares of Solventum by 19.8% during the 3rd quarter. Radnor Capital Management LLC now owns 10,174 shares of the company’s stock worth $709,000 after buying an additional 1,678 shares during the last quarter.

Solventum Stock Down 2.8 %

Solventum stock opened at $75.69 on Friday. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. Solventum Co. has a fifty-two week low of $47.16 and a fifty-two week high of $85.92. The company has a market capitalization of $13.08 billion and a PE ratio of 27.52. The firm has a 50 day moving average price of $73.42 and a 200 day moving average price of $70.42.

Wall Street Analysts Forecast Growth

SOLV has been the subject of a number of recent analyst reports. Morgan Stanley raised their price target on shares of Solventum from $73.00 to $80.00 and gave the stock an “equal weight” rating in a report on Wednesday. Wells Fargo & Company raised their price target on shares of Solventum from $73.00 to $75.00 and gave the stock an “equal weight” rating in a report on Friday, February 28th. Mizuho raised their price target on shares of Solventum from $70.00 to $82.00 and gave the stock a “neutral” rating in a report on Monday. Bank of America raised their price target on shares of Solventum from $80.00 to $85.00 and gave the stock a “neutral” rating in a report on Wednesday, February 26th. Finally, The Goldman Sachs Group lifted their target price on shares of Solventum from $63.00 to $71.00 and gave the company a “sell” rating in a report on Monday. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $79.86.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.